Purpose: Quantitative fluorescent polymerase chain reaction (QF-PCR) allows for the rapid prenatal diagnosis of common aneuploidies. The main advantages of this assay are its low cost, speed, and automation, allowing for large-scale application. However, despite these advantages, it is not a routine method for prenatal aneuploidy screening in Korea. Our objective in the present study was to validate the performance of QF-PCR using short tandem repeat (STR) markers in a Korean population as a means for rapid prenatal diagnosis. Material and Methods: A QF-PCR assay using an Elucigene kit (Gen-Probe, Abingdon, UK), containing 20 STR markers located on chromosomes 13, 18, 21, X and Y, was performed on 847 amniotic fluid (AF) samples for prenatal aneuploidy screening referred for prenatal aneuploidy screening from 2007 to 2009. The results were then compared to those obtained using conventional cytogenetic analysis. To evaluate the informativity of STR markers, the heterozygosity index of each marker was determined in all the samples. Results: Three autosomes (13, 18, and 21) and X and Y chromosome aneuploidies were detected in 19 cases (2.2%, 19/847) after QF-PCR analysis of the 847 AF samples. Their results are identical to those of conventional cytogenetic analysis, with 100% positive predictive value. However, after cytogenetic analysis, 7 cases (0.8%, 7/847) were found to have 5 balanced and 2 unbalanced chromosomal abnormalities that were not detected by QF-PCR. The STR markers had a slightly low heterozygosity index (average: 0.76) compared to those reported in Caucasians (average: 0.80). Submicroscopic duplication of D13S634 marker, which might be a unique finding in Koreans, was detected in 1.4% (12/847) of the samples in the present study. Conclusion: A QF-PCR assay for prenatal aneuploidy screening was validated in our institution and proved to be efficient and reliable. However, we suggest that each laboratory must perform an independent validation test for each STR marker in order to develop interpretation guidelines of the results and must integrate QF-PCR into the routine cytogenetic laboratory workflow.
Introduction
Rapid prenatal detection of numerical chromosome abnormalities by quantitative fluorescent polymerase chain reaction (QF-PCR) allows for reliable prenatal diagnosis of trisomies 13, 18, and 21 1, 2) . QF-PCR is an alternative method for rapid aneuploidy detection (RAD) of common aneuploidies based on the amplification of chromosome-specific DNA short-tandem-repeat (STR) polymorphisms, offering an attractive alternative to fluorescent in situ hybridization (FISH). Efforts to compare FISH and QF-PCR have concluded that both perform well in terms of overall sensitivity and specificity 3, 4) . However, the FISH method is a labor-intensive procedure, and also requires quite a large amount of AF to perform both FISH and culture-based karyotyping.
Large-scale studies using QF-PCR for rapid prenatal diagnosis of major chromosome aneuploidies demonstrated that the method is highly efficient, reliable, and cost effective 5, 6) . The QF-PCR technique allows for detection of common aneuploidies-usually within 24-48h-and provides rapid reassurance for all women with normal results. This approach requires accurate, robust, and rapid assays with a well-considered selection of STR markers because the allele frequency and heterozygosity rates (or informativity) of STR markers vary among different populations 7) . Here, we report the QF-PCR results of 847 AF samples for trisomies 13, .
Materials and Methods
Conventional cytogenetic analyses were performed according to standard procedures 9) . (7) (p15.3p22) and 45,X,add (15) Table   2 ). The observed allele number of each STR marker was from 9 to 36 (Table 2 ). Twelve cases (1.4%)
showed D13S634 submicroscopic duplication patterns, which were in 1:1:1 or 2:1 ratios, with the normal pattern of other STR markers for chromosome 13 and a normal karyotype (Fig. 1E ).
Discussion
QF-PCR was first introduced in 1993 10) . Over the years, this technique has been developed and made available for rapid prenatal diagnosis of common aneuploidies 11, 12) . Before the routine use of QF-PCR, FISH was the only molecular diagnostic technique for rapid prenatal diagnosis of aneuploidies, and, in many countries, has commonly been performed for more than 10 years 13) . Recently, some other molecular techniques, such as multiple ligation-dependent probe amplification (MLPA), have been introduced for the rapid screening of aneuploidies 14) . Individually, these methods have a number of advantages and disadvantages. The main advantages of QF-PCR are: (1) the small amount of AF required; (2) there is no need to culture fetal cells; and . Seven cases (0.8%, 7/847) not detected by QF-PCR (Fig. 1D ).
These patterns are not usually compatible with a normal, trisomic, or triploid result, so these samples can be safely tested without any risk of misdiagnosis. In the presence of low-level maternal cell contamination, the ratio between fetal STR peaks is not significantly altered; in these cases, diagnosis can be performed without great difficulty and in the presence of female fetuses by testing maternal DNA with the same markers. . In the present study, the STR markers for three autosomes (13, 18 Cho et al. 27) with the similar frequency (1.6%). A relatively high proportion of submicroscopic duplication patterns in D13S634, which is located in 13q21.33, might be a unique finding in the Korean population when compared with the data reported in Western countries 21) .
The STR submicroscopic duplication and somatic microsatellite mutation observed in the D21S11 marker in another Korean report, by Lee et al. 6) , was not detected in the present study.
In conclusion, QF-PCR for prenatal aneuploidy screening was validated in our institution and proved to be efficient and reliable. However, we suggest that each laboratory that uses this method perform an independent validation test in order to develop the interpreta- 
